Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans-Reference-Cited by-同舟云学术

Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans

Published:2021-03 Issue:3 Volume:11 Page:738-749
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Gao Yamin,Hameed H.M. Adnan,Liu Yang,Guo Lingmin,Fang Cuiting,Tian Xirong,Liu Zhiyong,Wang Shuai,Lu Zhili,Islam Md Mahmudul^ORCID,Zhang Tianyu^ORCID

Funder

Science and Technology Innovation Leader of Guangdong Province

National Mega-Project of China for Innovative Drugs

Chinese Academy of Sciences

Key-Area Research and Development Program of Guangdong Province

Economic Development of Marine Economy of Guangdong Province

State Key Laboratory of Respiratory Disease

Guangzhou Institute of Respiratory Diseases

Guangzhou Medical University

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference31 articles.

1. Mycobacterium ulcerans infection;van der Werf;Lancet,1999

2. Mycolactone: A polyketide toxin from Mycobacterium ulcerans required for virulence;George;Science,1999

3. Efficacy of the combination rifampin–streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans;Etuaful;Antimicrob Agents Chemother,2005

4. Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease;Sarfo;Antimicrob Agents Chemother,2010

5. Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer;Converse;PLoS Neglected Trop Dis,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Not only ClpC1 but also ClpX are drug targets of Ilamycins;2024-02-25

2. Recent Advances in the Management Strategies for Buruli Ulcers;Pathogens;2023-08-27

3. Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis;Frontiers in Cellular and Infection Microbiology;2022-08-24

4. Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-Oxazolidinone Derivatives as Antibacterial Agents;Frontiers in Chemistry;2022-07-18

5. Metagenomics Comparison of Buruli and Non Buruli Ulcer Skin Wound;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022